PMGC HoldingsELAB -5.32%8 Gross Margin % is 33.72% as of Mar. 2026, which is 25% below its 10-year median of 44.86. GuruFocus rates ELAB with a GF Score™ of 8/100. The stock has 1 warning sign investors should review. Among 738 Biotechnology companies, PMGC Holdings ranks worse than 74.66% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
PMGC Holdings had a gross margin of 33.72% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
PMGC Holdings Gross Margin % Related Terms
PMGC Holdings Gross Margin % Historical Data
* Premium members only.
The historical data trend for PMGC Holdings's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ELAB vs SYBX, CNSP, GNPX: Gross Margin % Comparison
For the Biotechnology subindustry, PMGC Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PMGC Holdings Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PMGC Holdings's Gross Margin % distribution charts can be found below:
* The bar in red indicates where PMGC Holdings's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
PMGC Holdings (ELAB) has a Gross Margin % of 33.72% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on PMGC Holdings and its competitors. This is 25% below median its historical median of 44.86. Over the past decade, PMGC Holdings' Gross Margin % has ranged from 31.36 to 58.36. According to the industry distribution chart, PMGC Holdings ranks #551 out of 738 companies in the Biotechnology industry, placing it in the top 74.7%.
Is PMGC Holdings' Gross Margin % too high?
PMGC Holdings' current Gross Margin % of 33.72% is 25% below median its 10-year median of 44.86. Over the past 10 years, this metric has ranged from a low of 31.36 to a high of 58.36. The Biotechnology industry median Gross Margin % is 60.94. PMGC Holdings' value of 33.72% is 44.7% below this industry median. Based on the distribution chart, PMGC Holdings ranks #551 out of 738 companies in the Biotechnology industry, which is below the industry midpoint. Overall, PMGC Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does PMGC Holdings' Gross Margin % compare to SYBX and CNSP?
According to the Biotechnology industry distribution chart, PMGC Holdings ranks #551 out of 738 companies for Gross Margin %. This places PMGC Holdings in the lower half of its industry. The industry median Gross Margin % is 60.94. PMGC Holdings' value of 33.72% is 44.7% below this benchmark. Historically, PMGC Holdings' own Gross Margin % has ranged from 31.36 to 58.36 over the past decade. While the company's 10-year median is 44.86 vs. the industry median of 60.94, PMGC Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.94, based on 738 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PMGC Holdings's current Gross Margin % of 33.72% is 44.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on PMGC Holdings and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PMGC Holdings's current Gross Margin % is 33.72%, which is 25% below median its own 10-year median of 44.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMGC Holdings stock overvalued right now?
PMGC Holdings (ELAB) has a current Gross Margin % of 33.72%. The current Gross Margin % is 33.72%, which is 25% below median its 10-year median of 44.86 and 44.7% below the Biotechnology industry median of 60.94. PMGC Holdings' overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For PMGC Holdings (ELAB), the current Gross Margin % is 33.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
8GF Score
Get the complete analysis for ELAB
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELAB has been successfully added to your 
